Cargando…

TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments

Generation of desired cell types by cell conversion remains a challenge. In particular, derivation of novel cell subtypes identified by single‐cell technologies will open up new strategies for cell therapies. The recent increase in the generation of single‐cell RNA‐sequencing (scRNA‐seq) data and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Mariana Messias, Okawa, Satoshi, del Sol, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848352/
https://www.ncbi.nlm.nih.gov/pubmed/33125830
http://dx.doi.org/10.1002/sctm.20-0227
_version_ 1783645116794142720
author Ribeiro, Mariana Messias
Okawa, Satoshi
del Sol, Antonio
author_facet Ribeiro, Mariana Messias
Okawa, Satoshi
del Sol, Antonio
author_sort Ribeiro, Mariana Messias
collection PubMed
description Generation of desired cell types by cell conversion remains a challenge. In particular, derivation of novel cell subtypes identified by single‐cell technologies will open up new strategies for cell therapies. The recent increase in the generation of single‐cell RNA‐sequencing (scRNA‐seq) data and the concomitant increase in the interest expressed by researchers in generating a wide range of functional cells prompted us to develop a computational tool for tackling this challenge. Here we introduce a web application, TransSynW, which uses scRNA‐seq data for predicting cell conversion transcription factors (TFs) for user‐specified cell populations. TransSynW prioritizes pioneer factors among predicted conversion TFs to facilitate chromatin opening often required for cell conversion. In addition, it predicts marker genes for assessing the performance of cell conversion experiments. Furthermore, TransSynW does not require users' knowledge of computer programming and computational resources. We applied TransSynW to different levels of cell conversion specificity, which recapitulated known conversion TFs at each level. We foresee that TransSynW will be a valuable tool for guiding experimentalists to design novel protocols for cell conversion in stem cell research and regenerative medicine.
format Online
Article
Text
id pubmed-7848352
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-78483522021-02-05 TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments Ribeiro, Mariana Messias Okawa, Satoshi del Sol, Antonio Stem Cells Transl Med Enabling Technologies for Cell‐based Clinical Translation Generation of desired cell types by cell conversion remains a challenge. In particular, derivation of novel cell subtypes identified by single‐cell technologies will open up new strategies for cell therapies. The recent increase in the generation of single‐cell RNA‐sequencing (scRNA‐seq) data and the concomitant increase in the interest expressed by researchers in generating a wide range of functional cells prompted us to develop a computational tool for tackling this challenge. Here we introduce a web application, TransSynW, which uses scRNA‐seq data for predicting cell conversion transcription factors (TFs) for user‐specified cell populations. TransSynW prioritizes pioneer factors among predicted conversion TFs to facilitate chromatin opening often required for cell conversion. In addition, it predicts marker genes for assessing the performance of cell conversion experiments. Furthermore, TransSynW does not require users' knowledge of computer programming and computational resources. We applied TransSynW to different levels of cell conversion specificity, which recapitulated known conversion TFs at each level. We foresee that TransSynW will be a valuable tool for guiding experimentalists to design novel protocols for cell conversion in stem cell research and regenerative medicine. John Wiley & Sons, Inc. 2020-10-08 /pmc/articles/PMC7848352/ /pubmed/33125830 http://dx.doi.org/10.1002/sctm.20-0227 Text en © 2020 The Authors. stem cells translational medicine published by Wiley Periodicals LLC on behalf of AlphaMed Press. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Enabling Technologies for Cell‐based Clinical Translation
Ribeiro, Mariana Messias
Okawa, Satoshi
del Sol, Antonio
TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments
title TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments
title_full TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments
title_fullStr TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments
title_full_unstemmed TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments
title_short TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments
title_sort transsynw: a single‐cell rna‐sequencing based web application to guide cell conversion experiments
topic Enabling Technologies for Cell‐based Clinical Translation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848352/
https://www.ncbi.nlm.nih.gov/pubmed/33125830
http://dx.doi.org/10.1002/sctm.20-0227
work_keys_str_mv AT ribeiromarianamessias transsynwasinglecellrnasequencingbasedwebapplicationtoguidecellconversionexperiments
AT okawasatoshi transsynwasinglecellrnasequencingbasedwebapplicationtoguidecellconversionexperiments
AT delsolantonio transsynwasinglecellrnasequencingbasedwebapplicationtoguidecellconversionexperiments